FL-2000 study for newly diagnosed follicular lymphoma patients with a high tumor burden
Phase of Trial: Phase III
Latest Information Update: 15 Dec 2008
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Etoposide; Interferon alpha-2a; Prednisolone
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 15 Dec 2008 Primary endpoint 'Event free survival rate' has been met.
- 02 Jul 2007 Status changed from in progress to completed
- 04 Dec 2005 New trial record.